Manufacturing of innovative medicines will be created in SEZ Technopolis Moscow

Moscow government and Promomed group of companies have agreed on cooperation in the sphere of creation of the research center and production of biotechnological products on the territory of a special economic zone (SEZ) Technopolis Moscow. The respective agreement within the framework of XXVI St. Petersburg International Economic Forum was signed by Vladislav Ovchinsky, the Head of the Department of Investment and Industrial Policy, which is a part of the Complex of Economic Policy and Property and Land Relations of the capital, and the Chairman of the Board of Directors of the company Peter Bely. In SEZ Technopolis Moscow on the site of Pechatniki it is planned to create a modern research laboratory with a pilot production area for the development of advanced drugs, scaling the technological processes, including the original ones. And at the site in Alabushevo the production of domestic biologics will be opened. The project will ensure the production of analogues of foreign drugs for the treatment of vital diseases, as well as create a solid technological base for the development and production of ultra-new domestic original drugs. "The new production will become part of the pharmaceutical cluster of the special economic zone. The research unit will be located at the Pechatniki site, and the production will be in Alabushevo. A plot of 3.2 hectares has been allocated for the enterprise construction. It is planned to create more than 400 working places. Investments in the project will amount to about 4.3 billion rubles", - said Vladislav Ovchinsky. It is planned that at the first stage the capacity of the pilot production site will be about 250 thousand vials of drugs per year. "With the support of the Moscow government on the site of Technopolis Moscow SEZ, the company is creating a center for full-cycle production of biotech drugs of the newest generations. Here we plan to develop a new line of biotech substances. We are grateful to the Moscow Government and personally to the Mayor of Moscow Sergey Sobyanin for supporting this important project for domestic medicine. For drug independence, we need our own innovative next-in-class and first-in-class drugs. They are the ones that will drive us forward. And signing this agreement is a significant step in this direction," commented Petr Belyi, Chairman of the company's Board of Directors. ___________________________________________________ Press service of the SEZ Technopolis Moscow Phone: +7 916 516-15-46 Mail: pr@technomoscow.ru [ mailto:pr@technomoscow.ru ] Subscribe to the SEZ "Technopolis Moscow" in social networks, follow the main news of the SEZ in telegram-channel [ https://t.me/technopolismoscow ]  and receive all the most important news delivered to your mail in our weekly newsletter [ http://events.technomoscow.ru/subscribe/?utm_source=site_technomoscow ] .